The 4-monthslong program is the result of a partnership between UCLA Health Biodesign and BioscienceLA, with its principal funding source being a $750,000 grant from the U.S. Economic Development Administration’s SPRINT Challenge. The inaugural class of innovators for the program were announced July 21.
“Our emphasis is on discovering and supporting innovations that benefit communities where the greatest needs are found, and our ability to leverage existing connections with bioscience industries and partnering organizations throughout the region,” Jennifer McCaney, executive director of UCLA Biodesign and assistant director of the UCLA Clinical and Translational Science Institute, told the Los Angeles Business Journal.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
